Our Mission: To drive the cost-effective and scalable production of recombinant proteins that contribute to improved health and nutrition
Our Vision: To sustainably produce therapeutics and alternative foods that are accessible and affordable to all populations for the betterment of global health and nutrition
Our Technology: Our team discovered the mechanism by which cells respond to all types of stress by reprogramming their translational machinery for “just-in-time” production of proteins essential for stress survival. Leveraging this novel biological insight, we can successfully express difficult-to-produce proteins, improve yields in any cell line, and shorten processing times. The unique biology of stress-induced translational reprogramming is tailored to the specific target protein, cell line, reactor environment, and manufacturing scale. These intricacies cannot be addressed solely through predictive AI and necessitate systems-based measurements. Our proprietary Epi-MAX platform technology succeeds by tuning the biology of protein-expressing cell lines to the complete biomanufacturing process, resulting in increases in protein yields up to 25-fold, thus far. This success is attributed to our approach of enhancing translation through a comprehensive multi-omics analytical and informatics platform, which evaluates cell behavior during protein over-expression. Subsequently, we re-engineer the expression system at every level, from vector to cell line, to effectively enhance the yield of functional protein in response to the cell’s environmental conditions
Our Applications:
1. Difficult-to-express proteins
2. Maintaining high protein yields as production scales
3. Strain engineering to leverage stress response mechanisms for enhanced functional recombinant protein synthesis
4. Tissue-specific expression of mRNA therapeutics
5. Gene therapy manufacturing: capsid assembly and payload expression
Company Details
- Employees
- 6
- Founded
- -
- Address
- 17 Briden St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.codomax.com
- Keywords
- Biologics Production, Biomanufacturing, Protein expression, Strain Engineering, Omics, Protein Production, Celllular agriculture, Alternative food proteins, Epitranscriptomics.
- HQ
- Worcester, Massachusetts
Codomax Questions
Codomax's website is http://www.codomax.com
Codomax's LinkedIn profile is https://www.linkedin.com/company/codomaxinc
Codomax has
6 employees.
View email and phone details for 6
employees at Codomax.
Codomax's industry is
Biotechnology Research
Codomax's top competitors are
Massachusetts Biomedical Initiatives (Mbi),
Lacerta Therapeutics,
Advirna,
Arrowbiome,
Hovana,
Raina Biosciences,
Velozbio,
Regeneron,
Sauvebio,
Leal Therapeutics.
Codomax's categories are Biotechnology Research
Codomax's founding year is 2022
